Pub. Date : 2009 Feb
PMID : 18472237
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | p53 expression in concurrent chemoradiotherapy with docetaxel for head and neck squamous cell carcinoma. | Docetaxel | tumor protein p53 | Homo sapiens |
| 2 | BACKGROUND: The current study aimed to evaluate the significance of an immunohistochemical assessment of tumor suppressor p53 as a prognostic marker in head and neck squamous cell carcinoma (HNSCC) patients treated with docetaxel and radiotherapy. | Docetaxel | tumor protein p53 | Homo sapiens |
| 3 | METHODS: The expression of tumor suppressor p53 and its phosphorylated form at the Ser392 residue was retrospectively evaluated by immunohistochemistry in 51 Stage T1-3N0-2M0 (except T1N0 glottis) HNSCC patients who were treated with 10mg/m(2)/week docetaxel four to six times and received concurrent chemoradiotherapy. | Docetaxel | tumor protein p53 | Homo sapiens |